Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2007-05-29
2009-11-24
Saoud, Christine J (Department: 1647)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C435S007100, C435S007210, C436S501000
Reexamination Certificate
active
07622256
ABSTRACT:
Methods of antagonizing MIF activity using ibudilast are described. Also described are methods of screening for MIF antagonists. These agents can be used for treating addictions, including drug and behavioral addictions, as well as for treating neuropathic pain.
REFERENCES:
patent: 2003/0195194 (2003-10-01), Gaeta et al.
patent: 2006/0008446 (2006-01-01), Watkins
patent: 2006/0160843 (2006-07-01), Johnson et al.
patent: 2007/0072899 (2007-03-01), Johnson et al.
patent: 2008/0114027 (2008-05-01), Johnson et al.
patent: 2008/0181876 (2008-07-01), Johnson et al.
patent: WO 99/64037 (1999-12-01), None
patent: WO 01/05422 (2001-01-01), None
patent: WO 03/104178 (2003-12-01), None
patent: WO 03/104203 (2003-12-01), None
patent: WO 2004/058713 (2004-07-01), None
patent: WO 2005/058304 (2005-06-01), None
patent: WO 2006/045505 (2006-05-01), None
patent: WO 2006/063048 (2006-06-01), None
patent: WO 2006/108671 (2006-10-01), None
patent: WO 2007/047978 (2007-04-01), None
Ledeboer et al. (2007). The glial modulatory drug AV411 attenuates mechanical allodynia in rat models of neuropathic pain. Neuron Glia Biology. 2:279-291.
Bloom & Bennett, “Mechanism of a reaction in vitro associated with delayed-type hypersensitivity,”Science153:80-82 (1966).
Calandra & Roger, “Macrophage migration inhibitory factor: a regulator of innate immunity,”Nat Rev Immunol3:791-800 (2003).
Calandra, et al., “Protection from septic shock by neutralization of macrophage migration inhibitory factor,”Nat Med6:164-170 (2000).
Feng, et al., “Ibudilast, A Nonselective Phosphodiesterase Inhibitor, Regulates Th l/Th2 Balance And NKT Cell Subset In Multiple Sclerosis,”Mult Scler10:494-498 (2004).
Fujimoto, et al., “Ibudilast, A Phosphodiesterase Inhibitor, Ameliorates Experimental Autoimmune Encephalomyelitis In Dark August Rat,”J Neuroimmunology95:35-42 (1999).
Futaki, “Treatment of Meniere's Disease Comparison of Prednisolone and Ketas,”Practica Otologica Kyoto83(9):1463-1471 (1990)English Abstract.
Gibson, et al., “The Inhibitory Profile of Ibudilast Against the Human Phosphodiesterase Enzyme Family,”Eur J Pharmacology538:39-42 (2006).
Gul, et al., “The interaction Between IL-1β and morphine: Possible Mechanism of the Deficiency of Morphine Induced Analgesia in Diabetic Mice,”Pain89:39-45 (2000).
Itoh, et al., “A Therapeutic Strategy To Prevent Morphine Dependence And Tolerance By Coadministration Of Camp-Related Reagents With Morphine,”Methods and Findings in Experimental and Clinical Pharmacology20(7):619-625 (1998).
Johnston, et al., “A Role for Proinflammatory Cytokines and Fractalkine in Analgesia, Tolerence and Subsequent Pain Felicitation Induced by Chronic Intrathecal Morphine,”J Neurosci24:7353-7365 (2004).
Kawanokuchi, et al., “Effects Of Interferon-Beta on Microglial Functions As Inflammatory And Antigen Presenting Cells In The Central Nervous System,”Neuropharmacology46:734-742 (2004).
Koda, et al., “Up-Regulation Of Macrophage Migration-Inhibitory Factor Expression After Compression-Induced Spinal Cord Injury In Rats,”Acta Neuropathol108:31-36 (2004).
Mamiya, et al., “Involvement of Cyclic AMP Systems in Morphine Physical Dependence in Mice: Prevention of Development of Morphine Dependence by Rolipram, A Phosphodiesterase 4 Inhibitor,”Br J Pharmacol132(5):1111-1117 (2001).
Mizuno, et al., “Neuroprotective Role Of Phosphodiesterase Inhibitor Ibudilast On Neuronal Cell Death Induced By Activated Microglia,”Neuropharmacology46:404-411 (2004).
Nabeshima, et al., “Drug Dependence Formation Inhibitor: Comprising Phosphodesterase Inhibitor, Preferably Rolipram, Especially for Combatting Narcotic Anaslgesic Dependence,” Database WPI, Derwent Publications, Ltd., London, GB p. 7, AN 1997-506303 (1997).
Narita, et al., “Role Of Astrocytes in Rewarding Effects Of Drugs Of Abuse,”Jpn J Neuropsychopharmacol26:33-39 (2006) English Abstract.
Narita, et al., “Direct Evidence of Astrocytic Modulation in the Development of Rewarding Efects Induced by Drugs of Abuse,”Neuropsychopharmacology31:2476-2488(2006).
Narita, et al., “Comparatice Pharmacological Profiles of Morphine and Oxycodone Under a Neuropathic Pain-Like State in Mice: Evidence for Less Sensitivity to Morphine,”Nature Neuropsychopharmacolog1-16 (2007)Online Article.
Obernolte, et al., “The cDNA of a Human Lymphocytic Cyclic-AMP Phosphodiesterase (PDE IV) Reveals a Multigene Family,”Gene129:239-247 (1993).
Raghavendra, et al., “The Role of Spinal Neuroimmune Activation in Morphine Tolerence/Hyperalgesia in Neuropathic and Sham-Operated Rats,”J Neurosci22(22):9980-9989 (2002).
Raghavendra, et al., “Attenuation of Morphine Tolerence, Withdrawal-Induced Hyperalgesia and Associated Spinal Inflammatory Immune Responses by Propentofylline in Rats,”Neuropsychopharmacology29(2):327-334 (2004).
Rile, et al., “Potentiation of Ibudilast Inhibition of Platelet Aggregation of Endothelial Cells,”Thrombosis Research102:239-246 (2001).
Santos & Morand, “The Role Of Macrophage Migration Inhibitory Factor In The Inflammatory Immune Response And Rheumatoid Arthritis,”Wein Med Wochenschr156:11-18 (2006).
Shavit, et al., “Interleukin-1 ANtogonizes Morphine Analgesia and Underlies Morphine Tolerance,”Pain115:50-59 (2005).
Song, et al., “The Involvement of Glial Cells in the Development of Morphine Tolerance,”Neurosci Res39:281-286 (2001).
Souness, et al., “Possible Role of Cyclic AMP Phosphdiesterases in the Actions of Ibudilast on Eosinophil Thrmbaxane Generation and Airways Smooth Muscletone,”Br J Pharmacol111:1081-1088 (1994).
Sugiyama, et al., “SPECT Evaluation of Effect of Cerebral Vasodilator by the Subtraction Method Using Tc-99m HMPAO,”No To Shinkei45(2):139-142 (1993)English Abstract.
Suzumura, et al., “Ibudilast Suppresses Tnfalpha Production By Glial Cells Functioning Mainly As Type III Phosphodiesterase Inhibitor In The CNS,”Brain Res837:203-212 (1999).
Takuma, et al., Ibudilast Attenuates Astrocyte Apoptosis Via Cyclic GMP Signalling Pathway in an In Vitro Reperfusion Model,Br J Pharmacology133:841-848 (2001).
Tsuru, et al., “Preference Test of 3-Isobutyry1-2-Isopopylpyrazolo [1,56-a] Pyradine (KC-404) On Rats,”Pharmacometrics36(6):449-457 (1988)English Abstract.
Wakita, et al., “Ibudilast Phosphodiesterase Inhibitor, Protects Against White Matter Damage Under Chronic Cerebral Hyperfusion in the Rat,”Brain Res992:53-59 (2003).
Watkins, et al., “Glia: Novel Counter-Regulators Of Opoid Analgesia,”Trends in Neurosci28:661-669 (2005).
Watkins, et al., “Beyond Neurons : Evidence That Immune and Glial Cells Contribute to Pathalogical Pain States,”Physiol Rev82:981-1011 (2002).
Watkins, et al., “Targeting Glia to Control Clinical Pain: An Idea Whose Time has Come,”Drug Disc Today1(1):83-88 (2004).
Bender, et al., “Cyclic Nucleotide Phosphodiesterases: Molecular Regulation To Clinical Use,”Pharmacol Rev58:488-520 (2006).
Castro, et al., “Cyclic Nucleotide Phosphodiesterases And Their Role In Immunomodulatory Responses: Advances In The Development Of Specific Phosphdiesterase Inhibitors,”Medicinal Res Rev25(2):229-244 (2005).
He, et al., “Novel Cyclic Compounds As Potent Phosphdiesterase 4 Inhibitors,”J Med Chem41:4216-4223 (1998).
Huang, et al., “Preferential Inhibition Of Human Phosphodiesterase 4 By Ibudilast,”Life Sci78:2663-2668 (2006).
Johnson, et al., “72 AV411: A Unique, Orally Active Glial Inhibitor For Neuropathic Pain,” Eur J Pain 10(1):S21 (2006).
Kiritsy-Roy, et al., “Dopamine D-1 And D-2 Receptor Antagonists Potentiate Analgesic And Motor Effects Of Morphine,”Pharmacol Biochem Behav32:717-721 (1989).
Ledeboer,
Gaeta Federico C. A.
Gross Matthew
Johnson Kirk W.
Vijay Sharmila
Avigen, Inc.
Lockard Jon M
Robins & Pasternak LLP
Saoud Christine J
LandOfFree
Method for selecting compounds that modulate MIF-induced... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for selecting compounds that modulate MIF-induced..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for selecting compounds that modulate MIF-induced... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4112317